Navigation
Search
|
The Maker of Ozempic Is Trying to Block Compounded Versions of Its Blockbuster Drug
Wednesday October 23, 2024. 04:27 PM , from Wired: Tech.
Novo Nordisk has asked the FDA to block production of compounded copies of Ozempic, arguing that it’s too difficult to do safely. It’s the latest escalation in a brewing war between pharmaceutical companies and compounders.
https://www.wired.com/story/novo-nordisk-ozempic-compounded-fda-block-pharmacies/
Related News |
25 sources
Current Date
Nov, Sat 23 - 10:44 CET
|